--- title: "C21 Investments (CWLXF) stock: news and investor profile" url: "https://aibio.space/companies/c21-investments/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "C21 Investments Inc. (OTC: CWLXF), United States. Listing facts, related biotech companies and news on aibio.space." --- CWLXF C21 Investments Inc. OTC · United States # C21 Investments (CWLXF) news C21 Investments Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker CWLXF, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest C21 Investments news We have not published a story on C21 Investments yet. When there is news, it will appear here. ## C21 Investments at a glance - **Ticker**: CWLXF - **Listing**: OTC - **Country**: United States ### Related companies - [DENTSPLY SIRONA](https://aibio.space/companies/dentsply-sirona/) NASDAQ: XRAY - [Nu-Med Plus](https://aibio.space/companies/nu-med-plus/) OTC: NUMD - [Profusa](https://aibio.space/companies/profusa/) NASDAQ: PFSA - [Vicarious Surgical](https://aibio.space/companies/vicarious-surgical/) OTC: RBOT - [TELEFLEX INC](https://aibio.space/companies/teleflex/) NYSE: TFX - [OPKO HEALTH, INC.](https://aibio.space/companies/opko-health/) NASDAQ: OPK - [Synergy CHC](https://aibio.space/companies/synergy-chc/) OTC: SNYRQ - [NeuroPace](https://aibio.space/companies/neuropace/) NASDAQ: NPCE ### Also on OTC - [Nu-Med Plus](https://aibio.space/companies/nu-med-plus/) NUMD - [Vaccinex](https://aibio.space/companies/vaccinex/) VCNX - [NANOLOGIX INC](https://aibio.space/companies/nanologix/) NNLX - [Aridis Pharmaceuticals](https://aibio.space/companies/aridis-pharmaceuticals/) ARDS - [PetVivo Holdings](https://aibio.space/companies/petvivo/) PETV - [Asep Medical Holdings](https://aibio.space/companies/asep-medical/) SEPSF ## What C21 Investments does C21 Investments Inc. is a British Columbia company that has focused on the cannabis market since January 2018, with growth based mainly on its acquisition and optimization of assets in Nevada. Its Silver State businesses operate indoor cannabis cultivation and processing in a licensed facility in Sparks, Nevada, and own three retail licenses for dispensaries in Sparks, Reno and Fernley. Most cultivation output is sold through its Silver State dispensaries, and excess production is sold into the wholesale market. The company acquired a South Reno dispensary from Deep Roots Harvest Inc. on June 7, 2024, and rebranded it Silver State. Its strategy for the next 12 months includes extending its Nevada retail footprint and internally producing product to supply those stores. The company operates from leased properties, with lease terms running to dates in 2027 and 2034, and it holds purchase options on some real estate. Its financings have included private placements and convertible debentures, and the note owed to the vendor of Silver State was fully repaid on June 1, 2023. The company reports its financial statements in Canadian dollars. | Product or program | What it is | Stage | |---|---|---| | Silver State cultivation and processing | Indoor cannabis cultivation and processing in a licensed Sparks, Nevada facility | operating | | Silver State dispensaries | Retail cannabis dispensaries in Sparks, Reno and Fernley, Nevada | operating | Summarised from the company's [20-F filed Jun 12, 2026](https://www.sec.gov/Archives/edgar/data/831609/000106299326003168/form20f.htm). ## C21 Investments annual financials | Line | FY ended Mar 31, 2026 | FY ended Mar 31, 2025 | |---|---|---| | Revenue | [$32.6 million](https://www.sec.gov/Archives/edgar/data/831609/000106299326003168/) | [$30.1 million](https://www.sec.gov/Archives/edgar/data/831609/000106299326003168/) | | Net income (loss) | [-$3.2 million](https://www.sec.gov/Archives/edgar/data/831609/000106299326003168/) | [-$4.0 million](https://www.sec.gov/Archives/edgar/data/831609/000106299326003168/) | Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about C21 Investments What is the ticker symbol of C21 Investments? C21 Investments Inc. trades under the ticker CWLXF on OTC. Where is C21 Investments listed? C21 Investments Inc. is listed on OTC. Which country or territory is C21 Investments listed under? Our directory records C21 Investments Inc. under United States. Does aibio.space cover C21 Investments? aibio.space lists C21 Investments Inc. among 2,820 public biotech companies and publishes its news here as stories appear. What does C21 Investments develop? C21 Investments Inc. is a British Columbia company that has focused on the cannabis market since January 2018, with growth based mainly on its acquisition and optimization of assets in Nevada. Its Silver State businesses operate indoor cannabis cultivation and processing in a licensed facility in Sparks, Nevada, and own three retail licenses for dispensaries in Sparks, Reno and Fernley. What is Silver State cultivation and processing from C21 Investments? Silver State cultivation and processing: Indoor cannabis cultivation and processing in a licensed Sparks, Nevada facility Stage: operating. What is Silver State dispensaries from C21 Investments? Silver State dispensaries: Retail cannabis dispensaries in Sparks, Reno and Fernley, Nevada Stage: operating. What was C21 Investments's revenue last year? $32.6 million for the fiscal year ended Mar 31, 2026, as reported to the SEC. Is C21 Investments profitable? C21 Investments Inc. reported a net loss of $3.2 million for the fiscal year ended Mar 31, 2026, per its annual report to the SEC. ## Investor discussion: C21 Investments Members talk about C21 Investments (CWLXF). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at C21 Investments, newest first. Each line links the filing it comes from. 1. 2026-08-26 Listings Filed to end its SEC reporting. SEC Form 15-12G. [Source](https://www.sec.gov/Archives/edgar/data/831609/000106299326004650/form1512g.htm) 2. 2026-06-15 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/831609/000106299326003202/exhibit99-1.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open OTC:CWLXF on TradingView](https://www.tradingview.com/symbols/OTC-CWLXF/). ## Listing details C21 Investments Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker CWLXF, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: C21 Investments Inc. - **Ticker**: CWLXF - **Listing**: OTC - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/c21-investments/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "C21 Investments (CWLXF) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/c21-investments/